The Beneficial Effect of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia (HIT 2)
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning
Standard
The Beneficial Effect of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia (HIT 2). / Bhardwaj, Priya; Petersen, Jan Roland; Fornitz, Gitte Gleerup.
I: SM Journal of Clinical Medicine, Bind 4, Nr. 1, 2018, s. 1034.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning
Harvard
Bhardwaj, P, Petersen, JR & Fornitz, GG 2018, 'The Beneficial Effect of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia (HIT 2)', SM Journal of Clinical Medicine, bind 4, nr. 1, s. 1034. <https://smjournals.com/clinical-medicine/fulltext/smjcm-v4-1034.php>
APA
Bhardwaj, P., Petersen, J. R., & Fornitz, G. G. (2018). The Beneficial Effect of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia (HIT 2). SM Journal of Clinical Medicine, 4(1), 1034. https://smjournals.com/clinical-medicine/fulltext/smjcm-v4-1034.php
Vancouver
Bhardwaj P, Petersen JR, Fornitz GG. The Beneficial Effect of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia (HIT 2). SM Journal of Clinical Medicine. 2018;4(1):1034.
Author
Bibtex
@article{d5f425c6c1224acc8e5e3b46527a9277,
title = "The Beneficial Effect of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia (HIT 2)",
author = "Priya Bhardwaj and Petersen, {Jan Roland} and Fornitz, {Gitte Gleerup}",
year = "2018",
language = "English",
volume = "4",
pages = "1034",
journal = "SM Journal of Clinical Medicine",
issn = "2573-3680",
number = "1",
}
RIS
TY - JOUR
T1 - The Beneficial Effect of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia (HIT 2)
AU - Bhardwaj, Priya
AU - Petersen, Jan Roland
AU - Fornitz, Gitte Gleerup
PY - 2018
Y1 - 2018
M3 - Journal article
VL - 4
SP - 1034
JO - SM Journal of Clinical Medicine
JF - SM Journal of Clinical Medicine
SN - 2573-3680
IS - 1
ER -
ID: 222105370